Osterweis Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Osterweis Capital Management's RGEN Position: Q3 2026 in Review
Osterweis Capital Management reduced its Repligen (RGEN) stake by 21% in Q3 2026, selling an estimated $3.73M and leaving 88,075 shares worth $16.9M. The position accounts for 0.84% of the portfolio, ranked #39.
Osterweis Capital Management first reported a position in RGEN in Q2 2024 and has held it in 9 quarters since. 524 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Osterweis Capital Management held 88,075 shares of Repligen worth $16.9M as of Q3 2026.
- Osterweis Capital Management sold 22,920 Repligen shares in Q3 2026, an estimated $3.73M.
- Repligen made up 0.84% of Osterweis Capital Management's portfolio in Q3 2026, its #39 holding.
- Osterweis Capital Management first reported a position in Repligen in Q2 2024 and has held it in 9 quarters since.
- 524 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Osterweis Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.